Delivery Order SPE2DB20D3103-SPE2DB21FN3T6
Award Date
4/21/21
Potential Completion Date
4/22/21
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chesterbrook, PA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through November 2026, serving as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) and other federal...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. Under this contract, Amerisourcebergen will deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides pharmaceutical products and medical supplies to the U.S. government. The contract, awarded by the Defense Logistics Agency (DLA), is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical and medical commodities, including specialty...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other government agencies. The contract is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. It serves as the primary vehicle for Amerisourcebergen to deliver specialty,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00, runs through November 2026 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers a wide array...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The Indefinite Delivery Contract (IDC), valued up to $999,999,999.00 through December 31, 2025, is the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. This includes specialty,...
This federal contract award was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and other federal healthcare programs. The contract, awarded by the Defense Logistics Agency (DLA), is a $999,999,999.00 Indefinite Delivery Contract (IDC) that runs through November 2026. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen will deliver a comprehensive range of pharmaceutical products and...
The U.S. government agency Defense Logistics Agency (DLA) awarded a federal contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, which has an Indefinite Delivery Contract (IDC) vehicle valued up to $999,999,999.00 through December 31, 2025, enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. This single-award IDC serves as...